triple negative breast cancer
Showing 1 - 25 of 307
Triple Negative Breast Cancer, High Grade Serous Ovarian Cancer, Endometrial Cancer Trial in Oklahoma City, Houston (AO-252)
Recruiting
- Triple Negative Breast Cancer
- +2 more
-
Oklahoma City, Oklahoma
- +1 more
Nov 13, 2023
Triple Negative Breast Cancer, Residual Disease Trial (Tetrathiomolybdate, Capecitabine, Pembrolizumab)
Not yet recruiting
- Triple Negative Breast Cancer
- Residual Disease
- Tetrathiomolybdate
- +2 more
- (no location specified)
Nov 15, 2023
Adult Soft Tissue Sarcoma, Non Small Cell Lung Cancer, Triple Negative Breast Cancer Trial in France (Ezabenlimab + BI907828)
Not yet recruiting
- Adult Soft Tissue Sarcoma
- +4 more
- Ezabenlimab + BI907828
-
Bordeaux, France
- +5 more
Oct 19, 2023
ctDNA During Neoadjuvant Chemotherapy for Breast Cancer.
Recruiting
- Breast Cancer Female
- +4 more
-
Ho Chi Minh City, Vietnam
- +1 more
Oct 16, 2023
Triple Negative Breast Cancer Trial (Sacituzumab govitecan, Pembrolizumab)
Not yet recruiting
- Triple Negative Breast Cancer
- Sacituzumab govitecan
- Pembrolizumab
- (no location specified)
Oct 5, 2023
Triple Negative Breast Cancer, Clear Cell Renal Cell Carcinoma, Ovarian Cancer Trial in Austin, San Antonio, Fairfax (BDC-3042,
Recruiting
- Triple Negative Breast Cancer
- +5 more
-
Austin, Texas
- +2 more
Sep 19, 2023
Triple Negative Breast Cancer, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial (ONM-501, Cemiplimab)
Not yet recruiting
- Triple Negative Breast Cancer
- +13 more
- (no location specified)
Aug 29, 2023
Triple Negative Breast Cancer Trial in Los Angeles (biological, procedure, drug)
Not yet recruiting
- Triple Negative Breast Cancer
- Aldesleukin
- +12 more
-
Los Angeles, CaliforniaUSC / Norris Comprehensive Cancer Center
Aug 9, 2023
Triple Negative Breast Cancer, Metastatic Breast Cancer, Mutation Trial in Shanghai (Everolimus, Investigator's Choice of
Not yet recruiting
- Triple Negative Breast Cancer
- +2 more
- Everolimus
- Investigator's Choice of Chemotherapy
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jul 25, 2023
Head Neck Cancer, Cervical Cancer, Endometrial Cancer Trial (ILB-2109, Toripalimab)
Not yet recruiting
- Head and Neck Cancer
- +9 more
- (no location specified)
Jul 12, 2023
Triple Negative Breast Cancer, HER2-positive Breast Cancer Trial in Seoul (exosome and ctDNA evaluation)
Active, not recruiting
- Triple Negative Breast Cancer
- HER2-positive Breast Cancer
- exosome and ctDNA evaluation
-
Seoul, Korea, Republic ofJi-Yeon Kim
Jul 13, 2023
Checkpoint Inhibitors in Triple Negative Breast
Recruiting
- Triple Negative Breast Cancer
- Whole Genome Sequencing
- +7 more
-
Barcelona, SpainVall d'Hebron Institute of Oncology
Jun 20, 2023
Triple Negative Breast Cancer, Neoadjuvant Chemo, Pembrolizumab Trial in Seoul (Visium, Whole Genome Sequencing(WGS)/Whole
Recruiting
- Triple Negative Breast Cancer
- +3 more
- Visium, Whole Genome Sequencing(WGS)/Whole Transcriptome Sequencing(WTS)
-
Seoul, Korea, Republic ofSamsung Medical Center
Jun 15, 2023
Breast Cancer, Triple Negative Breast Cancer Trial (Antivascular therapy, Chemotherapy)
Not yet recruiting
- Breast Cancer
- Triple Negative Breast Cancer
- Antivascular therapy
- Chemotherapy
- (no location specified)
Jun 11, 2023
Triple Negative Breast Cancer, Nonsmall Cell Lung Cancer Trial in Rocky Mount
Recruiting
- Triple Negative Breast Cancer
- Nonsmall Cell Lung Cancer
-
Rocky Mount, North CarolinaAccellacare of Rocky Mount -Dr. Bondy
May 26, 2023
Triple Negative Breast Cancer Trial in Dhaka (Doxorubicin, Cyclophosphamide, Paclitaxel)
Not yet recruiting
- Triple Negative Breast Cancer
- Doxorubicin
- +3 more
-
Dhaka, BangladeshBangabandhu Sheikh Mujib Medical University
May 24, 2023
HER2-positive Breast Cancer, Metastatic Cancer, Metastatic Breast Cancer Trial in Chicago, Minneapolis (ALX148, Fam-Trastuzumab
Recruiting
- HER2-positive Breast Cancer
- +17 more
- ALX148
- Fam-Trastuzumab Deruxtecan-Nxki
-
Chicago, Illinois
- +1 more
May 19, 2023
Metastatic Breast Cancer, Triple Negative Breast Cancer, Estrogen-receptor-low Breast Cancer Trial in Carmel, Indianapolis
Not yet recruiting
- Metastatic Breast Cancer
- +2 more
-
Carmel, Indiana
- +2 more
Apr 27, 2023
Triple Negative Breast Cancer Trial (Proleukin 1.3 MG Injection)
Not yet recruiting
- Triple Negative Breast Cancer
- Proleukin 1.3 MG Injection
- (no location specified)
Apr 6, 2023
Leptomeningeal Disease, Triple Negative Breast Cancer, HER2-positive Breast Cancer Trial in Tampa (Dendritic Cell Vaccine)
Recruiting
- Leptomeningeal Disease
- +2 more
- Dendritic Cell Vaccine
-
Tampa, FloridaMoffitt Cancer Center
Apr 11, 2023
Triple Negative Breast Cancer Trial (Ociperlimab, Tislelizumab, Paclitaxel)
Not yet recruiting
- Triple Negative Breast Cancer
- Ociperlimab
- +7 more
- (no location specified)
Mar 30, 2023
Triple Negative Breast Cancer Trial (Cryoablation, Cryoablation combined with PD1 Inhibitor)
Not yet recruiting
- Triple Negative Breast Cancer
- Cryoablation
- Cryoablation combined with PD1 Inhibitor
- (no location specified)
Mar 28, 2023